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Background: Variable degrees of differentiation in hepatocellular carcinoma(HCC)under Edmondson-Steiner
grading system has been proven to be an independent prognostic indicator for HCC. Up till now, there has
been no effective radiological method that can reveal the degree of differentiation in HCC before surgery.
This paper aims to evaluate the use of Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging combined with
T1 mapping for the diagnosis of HCC and assessing its degree of differentiation.
Methods: Forty-four patients with 53 pathologically proven HCC had undergone Gd-EOB-DTPA enhanced MRI
with T1 mapping before surgery. Out of the 53 lesions,13 were grade I, 27 were gradeII, and 13 were grade III.
The T1 values of each lesion were measured before and at 20 min after Gd-EOB-DTPA administration (T1p and
T1e). The absolute reduction in T1 value (T1d) and the percentage reduction (T1d %) were calculated. The one-way
ANOVA and Pearson correlation were used for comparisons between the T1 mapping values.
Results: The T1d and T1d % of grade I, II and III of HCC was 660.5 ± 422.8ms、295.0 ± 99.6ms、276.2 ± 95.0ms
and 54.0 ± 12.2 %、31.5 ± 6.9 %、27.7 ± 6.7 % respectively. The differences between grade Iand II, grade Iand III
were statistically significant (p < 0.05), but there was no statically significant difference between grade II and III.
The T1d % was the best marker for grading of HCC, with a Spearman correlation coefficient of −0.676.
Conclusions: T1 mapping before and after Gd-EOB-DTPA administration can predict degree of differentiation in HCC.
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Hepatocellular carcinoma (HCC) ranks as the sixth
most common cancer worldwide and is responsible for
about 9 % of the cancer-related deaths globally [1].
Many new developments in medical imaging help to
improve detection, characterization, and prognostica-
tion of HCC, eg contrast-enhanced ultrasonography
(CEUS), multidetector computer tomography (MDCT), dif-
fusion weighted magnetic resonance imaging (DW-MRI),* Correspondence: liziping163@163.com; fst1977@163.com
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(http://creativecommons.org/publicdomain/zeand Gd-EOB-DTPA enhanced MRI [1–4]. Gadoxetic
acid is a hepatocyte-specific contrast agent with a pen-
dant ethoxybenzyl group covalently attached to the
extracellular contrast agent gadopentetate dimeglu-
mine, which can be taken up by functioning hepato-
cytes. It is eliminated in equal quantities by the urinary
and biliary systems [5–8]. Therefore, it enables the
assessment of tumor vascularity as well as other
hepatocellular-specific properties within the tumor.
Thus Gd-EOB-DTPA has been proven valuable in de-
tection and differential diagnosis of focal liver lesions,
especially between early HCC and dysplastic nodu-
le(DN) [3, 9]. As HCCs in different degree of differenti-
ation retain variable degree of normal liver function,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Edmondson-Steiner grade
Edmondson-Steiner grade
I Cells with abundant cytoplasm and minimal
nuclear irregularity
II Greater nuclear irregularity and prominent
nucleoli
III Increased nuclear pleomorphism and
angulation of the nuclei; Tumour giant cells
were also more commonly seen
IVa Poorly differentiated with marked nuclear
pleomorphism, hyperchromatism and
anaplasia
aLimited by study population, this study did not include HCC of Edmondson-
Steiner grade IV
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[10, 11].
Measurement of the T1 relaxation time in a lesion be-
fore and after Gd-EOB-DTPA administration allows
quantitative evaluation of Gd-EOB-DTPA uptake, which
potentially reveals related properties of the lesion [12].
Unlike MR signal intensity, which is affected by many
technical factors and variable MR imaging parameters,
T1 relaxation time is a characteristic of the imaged tis-
sue. T1 mapping can hence be used for quantitative mea-
surements and characterization of tissues [4, 12, 13].
T1mapping on Gd-EOB-DTPA-enhanced MRI has been
shown to be able to quantitatively distinguish hepatic
hemangiomas from metastatic tumors [5]. T1 mapping
on Gd-EOB-DTPA-enhanced MRI also showed signifi-
cant differences in T1 relaxation time in hepatobiliary
phase and its rate of decrease (Δ %) between normal
liver, non-alcoholic fatty liver disease (NAFLD) and
non-alcoholic steatohepatitis (NASH) [4]. This method
has also been successfully used to estimate liver func-
tion [12, 14].
As of to date, there has been no attempt to assess the
degree of differentiation of HCC by medical imaging
methods.
It has been established that Edmondson-Steiner grade
was an independent predictor for early recurrence in
HCC. Furthermore, Edmondson-Steiner grade has been
shown to be related to other markers of poor prognosis,
including microvascular invasion [15–19], expression of
Nemo-like kinase (NLK), Protein disulfide isomerase
(PDI), p21-activated protein kinase (PAK) 6, chemokine
receptor CCR9 [20–23].
Previous studies have shown that different grades of
HCCs appear differently on both dynamic contrast-
enhanced (DCE) magnetic resonance imaging (MRI)
and hepatobiliary-phase MR images. Well-differentiated
HCC tends to show signals closer to that of liver paren-
chyma and less conspicuous hypointensity Gd-EOB-DTPA
on hepatobiliary-phase images [10, 11, 24]. One study also
indicated that maximum sensitivity of Gd-EOB-DTPA en-
hanced MRI was only 69 % even when diagnostic criteria
including all previously reported pattern of HCC were
adopted, missing some well-differentiated and moderately
differentiated HCC [25]. It is noteworthy that the above
studies were based on qualitative assessment. We propose
the use of T1 mapping index on Gd-EOB-DTPA enhanced
MRI that might predict Edmondson-Steiner grade of




This is a retrospective study conducted in accordance
with ethical guidelines for human research and wascompliant with the Health Insurance Portability and Ac-
countability Act (HIPAA). As such, the study received
IRB or ethical committee approval, and the requirement
for informed consent was waived.
Between July 2012 and February 2015, 44 patients (41
males and 3 females) suffering from HCC who had
undergone gadoxetic acid-enhanced MRI with a 3.0
Tesla (T) system within a week before hepatectomy were
included. (Patients who were non-evaluable or with poor
images were excluded.) Pathological diagnosis and grad-
ing were made according to Edmondson-Steiner grading
system, see Table 1 [16, 19].
MR imaging protocol
All MRI examinations were conducted with a clinical 3T
whole body system (Magnetom Verio, Siemens Health-
care Sector, Erlangen, Germany). The body array coil
(3T; 8-channel body matrix coil) was used in all exami-
nations. All patients fasted for 6 ~ 8 h prior to examin-
ation and were trained for holding breath. Bellyband was
used during examination. The sequences employed are
listed in Table 2.
All patients received a body weight adjusted dose of
Gd-EOB-DTPA (Primovist ®, 0.1ml/kg body weight) ad-
ministered as bolus injection with a flow rate of 1ml/s,
flushed with 30 ml of normal saline at the same rate.
The T1 relaxation times were measured on both non-
contrast images and images obtained at 20mins after in-
jection of the Gd-EOB-DTPA.
Image analysis
The T1 maps of the liver were generated with the evalu-
ation tool for calculating T1 relaxation times (Siemens
Leonardo Syngo 2009B). T1 values on T1 mapping im-
ages were measured before and after the administration
of the contrast medium (recorded as T1p and T1e re-
spectively) as shown in Fig. 1. Regions of interest (ROIs)
were drawn in the most homogeneous appearing portion
of the lesion, avoiding tumor capsule, necrosis, fat and
vessels. Round ROIs were drawn as large as possible
Table 2 MRI sequences used in the study
Sequence TR(ms) TE(ms) FA Scan time (s) Slice thickness (mm) Matrix FOV
Plain scan
T1WI 225 2.2 70 19.42 6 200 × 320 258 × 330
T2WI 2000 91 150 106 6 410 × 512 350 × 350
VIBE-T1mapping 4.4 1.2 2,12 20.15 2 154 × 256 248 × 330
DCE
VIBE 3.3 1.2 13 8.21/phase 2 96 × 256 248 × 330
Hepatobiliary-phase
T1WI 225 2.2 70 19.42 6 200 × 320 258 × 330
VIBE-T1mapping 4.4 1.2 2,12 20.15 2 154 × 256 248 × 330
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were identical in size and shape on images before and
after contrast.
Two experienced radiologists drew the ROIs inde-
pendently, and would reach a consensus by consultation
if there were any conflict. Each lesion was measured for
3 times and the mean of 3 values was applied for calcu-
lating reduction of T1 values (T1d) after enhancement
and its reduction ratio (T1d %) as follows:
T1d ¼ T1p−T1e
T1d% ¼ T1p−T1eð Þ=T1p½ x100%
[8, 13]Fig. 1 a, b T1 values in T1 mapping images was measured before
(T1p) and after (T1e) administration of the contrast medium. The
two ROIs were chosen at the same place in the same lesionsT1 maps were also color-coded using a visualization
tool of the open source OsiriX imaging software.
Statistical analysis
All statistical analyses were done using SPSS (version
19.0, Statistical Package for Social Science,Chicago,USA).
A one-way analysis of variance (ANOVA) was used to
analyze differences of these values between different
Edmondson-Steiner grades. Spearman correlation was
also done between T1 mapping characteristics and dif-
ferent Edmondson-Steiner grades.
All statistical tests were two-sided and p value < 0.05
indicated significant difference.
Results
The median age of patients was 54.9 (range 37–77).
Altogether, 53 lesions in 44 patients confirmed and
graded by pathology were analyzed in the study.
Size
The lesion size of different grades showed no statistical
significance, as shown in Table 3.
Comparison of T1mapping for HCC in different
Edmondson-Steiner grade
HCC showed either hyperintensity or hypointensity on
T1WI, and hypointensity on hepatobiliary-phase im-
ages. The higher the Edmondson-Steiner grade, the
more conspicuous the difference between lesion and
normal liver parenchyma (Fig. 2). T1p, T1e, T1d andTable 3 Size of lesions for different Edmondson-Steiner grade
Edmondson-Steiner grade No. Diameters (mean, mm)a
I 13 31.3 ± 23.7
II 27 25.4 ± 23.5
III 13 38.8 ± 35.6
Total 53 30.1 ± 28.5
aThere was no statistically significant difference between three
groups (P = 0.389)
Fig. 2 Row a: T1 weightedimages, Row b: T2 weightedI image, Row c: arterial phase image, Row d: potal venous phase image, Row e: hepatobiliary
phase images; Row f: and Row g: T1 mapping of T1WI and hepatobiliary phase images; row h: corresponding pathological pictures. 1a-h, HCC
(Edmondson-Steiner grade I). Lesion appeared hyperintense on routine sequences and hypointense in hepatobiliary-phase; T1p 892ms, T1e
388 ms, T1d = 504 ms, T1d % = 56.50 %; cells showed abundant cytoplasm and minimal nuclear irregularity. 2a-h, HCC (Edmondson-Steiner
grade II), hypointense on T1WI and hepatobiliary phase images, “wash in and wash out”; T1p 1696 ms, T1e 1444 ms, T1d = 252 ms, T1d %
= 14.90 %. 3a-h, HCC (Edmondson-Steiner grade III), hyperintense on T2WI images, hypointense on T1WI and hepatobiliary phase images; T1p 2134
ms, T1e 1494 ms,T1d = 640 ms,T1d % = 30.00 %. 2-h and 3-h, nuclear pleomorphism increased with increase in Edmondson-Steiner grade
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shown in Fig. 3. There was no statistical significance of
T1p and T1e between three groups (p = 0.144, 0.059).
But both T1d and T1d % showed statistical differences
between the groups. T1d ranged from 141ms to 1913ms,
and T1d % from 14.8 to 74.8 %. In general, T1d and
T1d % decreased with increase in Edmondson-Steiner
grade.
Mutivariate analysis showed there was statistical sig-
nificance of T1d and T1d % between both grade I-grade
II and grade I-grade III (p < 0.05). However the data
from group II and group III were not different from one
another (p = 0.804,0.197) (Fig. 4).
Correlation analysis
Spearman Correlation analysis manifested positive cor-
relation between T1e and Edmondson-Steiner grade
(P < 0.05), as well as negative correlations between T1d
and Edmondson-Steiner grade, T1d % and Edmondson-
Steiner grade (P < 0.05). Of the above, T1d % had the best
correlation with a correlation index 0.676 (Table 4).
Discussion
This study showed that HCC of Edmondson-Steiner
grade I could be distinguished from grade II and III le-
sions using T1d and T1d %. The higher the grade, the
lower the T1d and T1d %. From the above, it was sug-
gested that uptake of Gd-EOB-DTPA decreases with in-
crease in Edmondson-Steiner grade. Generally, 5–10 %
of HCC are Edmondson-Steiner grade I lesions. But in
this study, grade I HCC accounted for 24.5 % (13/53) of
the samples, which could be due to the higher propor-
tion of small HCC in the sample [26].
Gd-EOB-DTPA has been widely used in the HCC evalu-
ation and proved to be helpful for its diagnosis, differential
diagnosis and grading. Some previous studies found that
hypointensity on gadoxetic acid–enhanced hepatobiliary
phase images and hyperintensity on high-b-value DWIFig. 3 Values of T1p, T1e, T1d, T1d % in different groups and all of the studsuggest well-differentiated HCCs rather than benign hepa-
tocellular nodules, and might predict worse histological
grades of HCC [27, 28]. Schelhorn et al. [29] also reported
that the enhancement patterns changed with different
grades of HCC. On the other hand, it has been shown that
50 % of well-differentiated HCCs exhibit isointensity or
hyperintensity in the hepatobiliary-phase, causing diffi-
culty in imaging diagnosis, especially in patients with
worse Child-Pugh class [10, 11, 24, 25, 30]. It is known
that cell morphology of well-differentiated HCC is simi-
lar to that of normal liver cell. The ultra microstruc-
tures of well-differentiated HCC cells as revealed by
electron microscope also exhibit similarities in cell nu-
cleus, organelle, contact of cell, etc. to that normal liver
cell. It is therefore believed that well-differentiated
HCC could have preserved liver cell functions [31],
which has also been suggested in an imaging study on
animal HCC model [32]. Uptake of Gd-EOB-DTPA in
hepatobiliary phase in HCC is determined by expres-
sion of OATP1B3, which expression varies in HCC of
different grades [33]. However, the minor difference be-
tween HCC of different grades, as well as between well-
differentiated HCC and normal liver tissue, could be
difficult to appreciate by qualitative assessment.
This study confirmed that quantitative analysis based
on T1 mapping allowed differentiation between different
grades of HCC. Of the different quantitative measure-
ments studied, T1d % had the best correlation with
histological grades. The results showed that T1d % for
grade I lesions was 54.0 ± 12.2 %, and that for grade II
and III lesions were 31.5 ± 6.9 and 27.7 ± 6.7 % respect-
ively. Therefore T1d % of higher than 50 % would sug-
gest that an HCC is likely to be of Edmondson-Steiner
grade I. Theoretically, T1p and T1e, could also be differ-
ent in different Edmondson-Steiner grades; however, this
was not supported by the results. It is suspected that this
could in part be related to abnormal blood perfusion
due to artery-to-vein or artery-to-portal vein shuntingied lesions
Fig. 4 The average value of T1d and T1d % in HCC of different Edmondson-Steiner grades. Box-and-whisker plots showed that there was
statistical significance of T1d and T1d % between grade I and the other two groups, but no statistically significant difference between grade II
and grade III lesions
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Gd-EOB-DTPA.
Previous studies have suggested that Edmondson-
Steiner grade is an independent factor affecting prog-
nosis/recurrence of HCC [15–20], which should be
taken into account when considering therapeutic strat-
egy [16, 19]. In addition, liver cells take up Gd-EOB-
DTPA via the receptors OATP1B1, OATP1B3 and
NTCP. OATP1B3 is also the transport for some anti-
cancer drugs [32, 35–39]. Therefore, tumor behavior
in terms of Gd-EOB-DTPA uptake might also predict
effect of therapy. The results obtained by this study
held promise to predict tumor grading patients prior
to surgery, which might also help to choose between
treatment options.
There are limitations in the current study. Firstly, the
retrospective nature of the study could not avoid sampling
bias. Secondly, due to the relatively small number of le-
sions, a model that describes the relations between the
best indicator of T1d % and the individual Edmondson-
Steiner grades could not be formulated.Table 4 Correlation analysis between T1p, T1e, T1d, T1d % and
Edmondson-Steiner grade
T1p T1e T1d T1d %
Correlation index −0.065 0.335 −0.570 −0.676a
P 0.643 0.014 0.000 0.000
N 53 53 53 53
aT1d % had the best correlation with Edmondson-Steiner grade with a correlation
index 0.676Conclusion
T1 mapping before and after Gd-EOB-DTPA adminis-
tration can help to classify the HCC in terms of
Edmondson-Steiner grade. The percentage reduction of
T1 value after contrast in hepatobiliary phase was the
best indication for such classification of HCC.
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